Subscribe

What are you looking for?

Main Menu

明報新聞網

諾華120億美元收購Avidity 溢價46%

Future Wealths
Future Wealths
27 10 月, 2025
One Min Read
2 Views
0 Comments
彭博社報道，瑞士製藥商諾華公司(Novartis)同意收購生物技術公司Avidity Biosciences Inc.，交易價值120億美元，這是該公司十多年來的最大一筆收購交易，並在其暢銷藥物面臨仿製藥的競爭之際為該公司帶來幾種潛在的重磅藥物。

原文: https://finance.mingpao.com/fin/instantf/20251027/1761538757889/%e8%ab%be%e8%8f%af120%e5%84%84%e7%be%8e%e5%85%83%e6%94%b6%e8%b3%bcavidity-%e6%ba%a2%e5%83%b946

Last Update: 27 10 月, 2025

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept